--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About URGN20260918C39
Biotechnology Ⅲ
Urogen Pharma Ltd. was established under the laws of the State of Israel in April 2004 as TheraCoat Ltd. In September 2015, the company changed its name to Urogen Pharma Ltd.. The company is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care in urological pathology.
